Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Co-trimoxazole in Severe COVID-19
NCT04884490Phase 3Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- May 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole in COVID-19 pneumonia, sponsored by Bangabandhu Sheikh Mujib Medical University. Started May 2021; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04884490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04884490.